Search icon
TCS, HDFCBANK, SBI Liquid Fund (G)
Aprameya Engineering Ltd.

APRAMEYA

Equity

NSE,BSE

Min. Investment

56,000.00

Open a free Demat account and invest in IPOs easily.

Download Orca

Google PlayApp Store

To access realtime data for GP Eco Solutions India Ltd. and use advance features for Applying IPO. Register or Login to Orca.

IPO Details

Bidding Dates

25 Jul 24 - 29 Jul 24

Price Range ₹

56 - 58

Total Equity

29.23Cr

Lot Size

2000

Exchange Status

NSE,BSE

IPO Doc

Subscription Rate

Non-Institutional Investor

0.00×

Qualified Institutional Buyers

0.00×

Employees

0.00×

Retail Investors

0.00×

Total subscription Rate

0.00×

IPO Timeline

Offer start

25 Jul 2024

Offer end

29 Jul 2024

Allotment

30 Jul 2024

Refund initiation

31 Jul 2024

Demat transfer

31 Jul 2024

Listing

01 Aug 2024

About Company

Incorporated in September 2003, Aprameya Engineering Limited specializes in installing and maintaining Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatres, and prefabricated structure wards in hospitals and medical care centers. They offer these services on a turnkey basis and also supply high-value healthcare and diagnostic equipment to private hospitals, government hospitals, and medical practitioners. The company’s products fall into two main categories: 1. Establishing healthcare infrastructure within hospitals and medical care centers. 2. Dealing in high-value medical equipment. Since 2020, Aprameya Engineering has been setting up ICUs and operation theatres, installing around 2,000 critical care beds, including ICUs, NICUs, and PICUs. They are also establishing modular operation theatres throughout Rajasthan. The company has four warehouses: two in Memnagar, Ahmedabad, one in Prahladnagar, Ahmedabad, and one on Ashram Road, Ahmedabad. Aprameya Engineering offers a wide range of medical equipment and solutions, including Electrosurgical Generators, Electrosurgical Units, CO2 Insufflators, LED Surgery Lights, Surgical and Medical Examination Lights, ICU Respiratory Monitoring Systems, ICU Ventilation Systems, Anesthesia Workstations, Jaundice Meters, Anesthesia Machines, and Harmonic Scales. As of August 31, 2023, the company employs 44 permanent staff members who handle day-to-day business operations, marketing, and accounting functions.

Year Founded

28-12-2021

Promotor Details

Saurabh Kishor Bhatt

Promoter Holdings Details

ParticularPre-IPOPost-IPO
Percentage1000
Share Capital140000000

Offer to Public

50,40,000.00 Cr

Project Details

  • None - Nonecr

Objectives

  • To meet incremental working capital requirements (including augmentation on Long Term Working Capital).General corporate purpose.

Highlights

  • Demonstrated rapid growth with a strong emphasis on establishing healthcare infrastructure.
  • Track record of successfully setting up ICUs, NICUs, PICUs, and Operation Theatres.
  • Established firm arrangements with numerous medical equipment suppliers and manufacturers.
  • Serves a wide range of customers, including many private and government hospitals and medical colleges.
  • Led by experienced promoters with a technical team possessing extensive domain knowledge.

Challenges

  • Loss of key customers or a significant reduction in demand from them could negatively impact the company’s business and financial performance. Additionally, many work orders are awarded through competitive bidding, with no assurance of future contracts.
  • The company's performance is heavily dependent on spending in the healthcare infrastructure industry. Any decline in this spending in India could adversely affect its business and profitability.
  • The Order Book may not accurately represent future results, and actual income could be significantly less than estimated, adversely affecting the company’s operations.
  • Diversification into setting up and maintaining ICUs, NICUs, PICUs, and Operation Theatres exposes the company to risks associated with new offerings, which may not be successfully implemented.
  • The company faces risks from relying on third parties for sourcing medical equipment. Failure of these suppliers to meet their obligations could adversely affect business operations and results.

Financials

YearsTotal AssetsShare CapitalProfit After TaxConsolidated Net ProfitAdjusted EPS
20236,172.681,400.00536.92536.923.8351
20224,854.37700.00536.92536.923.8351
Enrich money logo